Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide/Formoterol Inhalation Powder in Adults With Asthma
NCT07790159Phase 3Completed
- Sponsor
- Shanghai Xin Huanghe Pharmaceutical
- Start
- Feb 2024
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide, formoterol in asthma, sponsored by Shanghai Xin Huanghe Pharmaceutical. Started Feb 2024; status: completed.
02
Drugs
budesonideformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07790159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07790159.